Peer-reviewed veterinary case report
Zinc oxide nanoparticles fight drug-resistant cat urinary infections
By Sewid, Alaa H et al.·Published in Frontiers in cellular and infection microbiology·2024·Department of Microbiology·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Hexagonal zinc oxide nanoparticles: a novel approach to combat multidrug-resistantbiofilms in feline urinary tract infections.
- Species:
- cat
Plain-English summary
A domestic cat with a urinary tract infection (UTI) caused by a drug-resistant bacteria was studied to find better treatment options. Researchers tested a new treatment using hexagonal zinc oxide nanoparticles combined with streptomycin and Moringa leaf extract. This combination showed strong antibacterial effects and significantly reduced the bacteria's ability to form protective biofilms, which make infections harder to treat. The findings suggest that this new approach could help improve UTI treatments in cats, especially those with resistant infections.
People also search for: cat urinary tract infection treatment · drug-resistant UTI in cats · zinc oxide nanoparticles for feline UTIs
Abstract
INTRODUCTION: , a common inhabitant of the feline gastrointestinal tract, has emerged as a significant pathogen causing urinary tract infections (UTIs) in domestic cats. The rise of multidrug-resistantstrains and their propensity to form biofilms pose significant challenges in treatment. This study investigated the antibacterial and antibiofilm activities of hexagonal zinc oxide nanoparticles (ZnONPs) alone and in combination with streptomycin and Moringa oleifera leaf extract (MOLe) against multidrug-resistantisolates from feline UTIs. METHODS: Antimicrobial susceptibility testing was performed using the Kirby-Bauer disk diffusion method. Biofilm formation was assessed using the crystal violet assay, and biofilm-associated genes (,E,ABC) were detected by PCR. ZnONPs, Str/ZnONPs (streptomycin-loaded ZnONPs), and Str/MOLe@ZnONPs (streptomycin and MOLe-loaded ZnONPs) were characterized using FTIR, DLS, TEM, and SEM. The antibacterial and antibiofilm activities of the synthesized nanoparticles were evaluated through time-kill assays, well diffusion assays, and gene expression analysis. RESULTS: A high prevalence of multidrug resistance was observed among theisolates, with significant resistance to ampicillin, vancomycin, and streptomycin. Characterization studies revealed the successful encapsulation of streptomycin and MOLe within the ZnONPs.assays demonstrated that Str/MOLe@ZnONPs exhibited potent antibacterial and antibiofilm activities against the testedstrains, significantly reducing bacterial growth and biofilm formation. DISCUSSION: The emergence of multidrug-resistantstrains necessitates the development of novel therapeutic strategies. This study demonstrates the promising potential of ZnONPs, particularly those loaded with streptomycin and MOLe, in combating biofilm-forming. The synergistic effects of the combined formulation may offer a novel approach to overcome antibiotic resistance and improve the treatment outcomes ofUTIs in domestic cats.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/39926113/